Literature DB >> 25600803

Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.

Li-Bo Liu1, Hui Xie1, Yi-Xue Xue2, Yun-Hui Liu3, Zhen Li3, Ping Wang1.   

Abstract

The present study was performed to examine whether Endothelial-monocyte-activating polypeptide II (EMAP II) could inhibit glioma growth by inducing rat brain glioma C6 cells apoptosis. The results revealed that the EMAP II decreased cell viability of rat C6 glioma cells in a time-dependent manner. Apoptotic proportion was increased gradually after EMAP II. EMAP II induced the decrease in mitochondrial membrane potential and the release of cytochrome c into the cytosol, followed by activation of caspase-9 and caspase-3. Meanwhile, EMAP II-induced apoptosis was accompanied by an increase of reactive oxygen species (ROS). The significant up-regulation in the expressions of Bax and Apaf-1 as well as down-regulation in the expression of Bcl-2 was observed. The time course change of ROS was prior to the changes of above investigated indexes. All of these results strongly suggest that EMAP II could induce rat C6 glioma cells apoptosis via the mitochondrial pathway, and ROS, Bax/Bcl-2 might be involved in this processing.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bax; Bcl-2; EMAP II; Glioma; Reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 25600803     DOI: 10.1016/j.bbrc.2015.01.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells.

Authors:  Jiajia Chen; Libo Liu; Yunhui Liu; Xiaobai Liu; Chengbin Qu; Fanjie Meng; Jun Ma; Yang Lin; Yixue Xue
Journal:  Front Cell Neurosci       Date:  2016-05-17       Impact factor: 5.505

2.  The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.

Authors:  Jiahui Liu; Libo Liu; Shuo Chao; Yunhui Liu; Xiaobai Liu; Jian Zheng; Jiajia Chen; Wei Gong; Hao Teng; Zhen Li; Ping Wang; Yixue Xue
Journal:  Front Cell Neurosci       Date:  2017-12-19       Impact factor: 5.505

3.  Endothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy.

Authors:  Zhiqing Li; Jun Ma; Libo Liu; Xiaobai Liu; Ping Wang; Yunhui Liu; Zhen Li; Jian Zheng; Jiajia Chen; Wei Tao; Yixue Xue
Journal:  Front Mol Neurosci       Date:  2017-06-28       Impact factor: 5.639

4.  MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.

Authors:  Liangyu Chen; Yixue Xue; Jian Zheng; Xiaobai Liu; Jing Liu; Jiajia Chen; Zhen Li; Zhuo Xi; Hao Teng; Ping Wang; Libo Liu; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2018-02-07       Impact factor: 5.639

5.  EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma.

Authors:  Manal Mohamed Saber
Journal:  J Immunol Res       Date:  2022-09-12       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.